Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Risk Reduction Behavior 1Communication 1Colonic Neoplasms 1Behavior 1

Interventions

Fluorouracil 128Leucovorin 120Oxaliplatin 101Irinotecan 89Bevacizumab 55Cetuximab 44Capecitabine 40Folfox protocol 29Panitumumab 22Colonoscopy 17Chemotherapy, Adjuvant 16Floxuridine 15Early Intervention, Educational 15Erlotinib Hydrochloride 13Surveys and Questionnaires 11IFL protocol 11Counseling 11Immunohistochemistry 10Gemcitabine 10Celecoxib 10Psychiatric Rehabilitation 9Methods 8Magnetic Resonance Spectroscopy 8Gene Expression Profiling 8Exercise 8Dexamethasone 8sargramostim 7Sorafenib 7Radiotherapy 7Nivolumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Colonic Neoplasms × Price Transparency × Clear all
NCT04548765 2021-09-24

Evaluation of Letters Promoting Colorectal Cancer Testing

Geisinger Clinic

Phase NA Completed
14,644 enrolled
Gastrointestinal

Behavior, Colonic Neoplasms, Communication, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡